Form D — Bectas Therapeutics, Inc.
0002038826-25-000002 · filed 2025-10-08
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $5,550,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Bectas Therapeutics, Inc.
- CIK
- 2038826
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 3262 WESTHEIMER ROAD
HOUSTON, TX 77098 - Phone
- 617-834-3476
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ronan O'Hagan · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Lynda Chin · DirectorHouston, TX Find on LinkedIn ↗
-
Jon A. Brilliant · Executive OfficerHouston, TX Find on LinkedIn ↗
View original on SEC EDGAR.